Milbemycin Oxime Tablets for Cats - Effective Worm Protection

Name: Milbemycin Oxime Tablets for Cats - Effective Worm Protection
Brand: Guangzhou Pevet Pet Pharmaceutical Technology Co., Ltd.
SKU: 2273157725

Guangdong, ChinaGuangzhou Pevet Pet Pharmaceutical Technology Co., Ltd.

US$3.63

3-2,999 Pieces

US$2.82

3,000-4,999 Pieces

US$1.88

5,000+ Pieces

Sample price:US$3.00/piece.Request sample

Product profile

Customization

Available

Varieties

Parasite Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

14mg/56mg

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Moisture Proof

Veterinary Reg. No.

110683419

Product Name

Vet-Recommended Pet Dewormer Tablet

Main Ingredients

Milbemycin Oxime & Praziquantel

Applicable Objects

for Dogs Cats

Shelf Life

3 Years

Use

Removal Ascaris, Hookworm, Whipworm, Tapeworm

MOQ

3000PCS

Size

3pieces/Set, 60set/Box

Sample

Support

Our Service

Customized Packaging, Logo and Ingredient

ODM & OEM

Support

Specification

14mg/56mg

Trademark

Pevet

Origin

Rpc

Production Capacity

5000000/Year

Company profile

Full CustomizationR&D CapabilitiesProduction Process VisualizationHigh Repeat Buyers Choice

Guangzhou Pevet Pet Pharmaceutical Technology Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Export Year: 2020-06-02Nearest Port: guangzhouAverage Response Time: ≤2.04h

AI-Powered supplier vetting

SummaryThe supplier is identified as a factory in Baiyun District, Guangzhou, with a combined company type. It reports broad customization and ODM capabilities, recent new-product development, and documented procedures for finished-product inspection, service assessment, corrective actions, and complaint handling. After-sales support includes technical guidance, product training, and feedback handling. Export activity has continued for seven years, with 21%–30% of sales from exports and access to Guangzhou and Shenzhen ports. However, the supplier reports no overseas warehouse, showroom, agent or branch, SDK, offline trade-show participation, or OEM service for popular brands. Certification holdings and customer cases are not provided. Financial information is inconsistent or insufficient for credibility assessment because the supplied records show zero values for multiple financial metrics.

Supplier typeThe supplier is described as a factory located in Baiyun District, Guangzhou, and its company type is listed as "Combined." This supports classification as a manufacturing-oriented supplier, although the exact meaning of the combined type is not explained.

After-Sales capabilityThe supplier states that it provides technical guidance, product training, prompt feedback handling, and comprehensive service support. It also reports written and followed procedures for service assessment, corrective and preventive actions, and customer complaints, with lead times within 15 working days in both peak and off-seasons; however, it has no overseas warehouse, showroom, agent, or branch.

R&D capabilityThe supplier reports new products during the past year, broad R&D design services, and ODM availability. It does not have an available SDK, so its innovation capability is supported for product development and design services but not for SDK-based integration.

Production capacityThe supplier is identified as a factory and reports that finished-product inspection instructions exist and are uniformly followed. The slices do not provide production capacity, equipment, staffing, output volume, or manufacturing certifications, so production scale cannot be fully evaluated.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization scope, supplemented by reported ODM service availability.